Introducing FE International’s Newest Addition: Randal V. Stephenson, Veteran Investment Banker, to Spearhead Investment Banking Division

Welcome to the Future of Investment Banking with FE International A New Chapter Begins with the Hiring of Randal V. Stephenson May 22, 2023 FE International Inc. has made a bold move in the world of investment banking by bringing on board the experienced veteran Randal V. Stephenson as its Head of Investment Banking. This…

Read More

Important Deadlines Approaching for PAYC, ILMN, and JRVR: A Reminder from The Law Offices of Frank R. Cruz for Shareholders Facing Class Actions

Deadline Alert for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders LOS ANGELES, Nov. 17, 2023 (GLOBE NEWSWIRE) The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies….

Read More

Act Now: Don’t Miss the Deadline for EngageSmart Shareholders! ClaimsFiler Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against ESMT

New Orleans, Dec. 04, 2024 – ClaimsFiler Reminder for EngageSmart, Inc. Shareholders Don’t Miss the Deadline! ClaimsFiler, a FREE shareholder information service, is here to remind investors about the upcoming deadline in the securities class action lawsuit against EngageSmart, Inc. If you purchased or acquired EngageSmart common stock between October 23, 2023, and January 26,…

Read More

Uncovering Success: A Look at Discovery’s Third Quarter 2024 Financial Results

Discovery Silver Corp Announces Financial Results for Q3 2024 TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three months (“Q3 2024”) and nine months (“YTD 2024”) ended September 30, 2024. All figures are stated in Canadian dollars unless otherwise…

Read More

Innovative, Articulate, and Easy-to-Follow: A Professional and Blog-Friendly Rewrite of Accesswire View Article

New Patent Issued for Core Rare Disease Target Indication for Crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions,…

Read More